Sumários

Lesson 6

27 Setembro 2021, 13:00 • Maria Helena Mouriño Silva Nunes

The controversy over the calculation of DALY and QALY to support health policy decision-making.

An overview of some European health agencies about this issue, as for instance: ECHOUTCOME (European consortium in healthcare outcomes and cost-benefit research, FP7–Health project.

Lesson 5

27 Setembro 2021, 10:30 • Maria Helena Mouriño Silva Nunes

Description and interpretation of DALY and QALY.
Determination of DALY (in practice): a detailed study of the DALY calculations from articles in the literature.

Lesson 4

20 Setembro 2021, 13:00 • Maria Helena Mouriño Silva Nunes

Methodologies to assess the health and economic effects of alternative medical treatments.
Measures largely used in the CEA: Quality-Adjusted Life Year (QALY); Disability-Adjusted Life Year (DALY).

Lesson 3

20 Setembro 2021, 10:30 • Maria Helena Mouriño Silva Nunes

Cost-effectiveness analysis (CEA):
The issue of measuring the burden of disease. Introduction to cost-effectiveness analysis (CEA), the most widely applied tool to guide policy decisions concerning the allocation of healthcare resources. The differences between the healthcare systems and the conventional market of consumer goods. Failure of the law of demand and supply.

Incremental Cost-Effectiveness Ratio (ICER).

Lesson 2

13 Setembro 2021, 13:00 • Maria Helena Mouriño Silva Nunes

Fee-For-Service (FFS) models, which rely on the volume of the healthcare services.

Reimbursement of the healthcare systems. An overview.

A brief summary of the most common reimbursement models: the Beveridge model, the Bismark model, the National Health Insurance, and the out-of-pocket model.